Method for screening aptamer of small molecule target with regioselectivity
By inhibiting organic reactions based on nucleic acid-target binding, small molecule target nucleic acid aptamers with regional selectivity were screened, solving the problems of low screening efficiency and serious cross-reaction of small molecule target nucleic acid aptamers in traditional technology, and achieving High specificity and efficient enrichment.
Patent Information
- Application Number
- CN202310561070.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-17
- Publication Date
- 2024-11-22
AI Technical Summary
Traditional SELEX technology is difficult to effectively screen out high specific small-molecule target nucleic acid aptamers, especially in the presence of structural analogs in the sample, resulting in cross-reaction and inefficiency problems.
By inhibiting organic reactions of functional groups on the target based on nucleic acid-target binding, library heat treatment, activated magnetic beads or agarose spheres, magnetic beads or agarose spheres negative screening, library incubation and cross-linking, library with targets, and library incubation and cross-linking Reaction captures the nucleic acid sequence bound to the target, elution and PCR, and screens out small molecule target nucleic acid aptamers with regioselectivity.
It realizes efficient screening of small-molecular target nucleic acid aptamers, improves specificity and enrichment efficiency, overcomes the problems of solid-phase media interference and non-specific adsorption, and simplifies the operation process.
Smart Images

Figure CN118995724A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for screening nucleic acid aptamers of small molecule targets with regional selectivity, belonging to the field of biotechnology. Background Art
[0002] The screening technology of nucleic acid aptamers, i.e., Systematic Evolution of Ligands by Exponential Enrichment (SELEX) (Nature, 1990, 346 (6287), 818-822; Science, 1990, 249 (4968), 505-510.), is a nucleic acid aptamer in vitro screening technology based on in vitro synthetic library, polymerase chain reaction (PCR) and sequencing. The basic principle of SELEX technology is to incubate an oligonucleotide (DNA or RNA) library with a specific target molecule, separate the oligonucleotide bound to the target molecule by separation technology, perform exponential amplification by PCR technology, prepare the obtained product into a single-stranded secondary library, and use the secondary library as the starting library for the next round to restart a new round of screening. Through multiple rounds of screening process, nucleic acid aptamers with high affinity and high specificity are finally obtained.
[0003] Since its introduction, SELEX technology has been widely used in many fields. However, it is still very difficult to screen and obtain highly specific nucleic acid aptamers for small molecule targets using traditional SELEX technology. Actual samples often contain a variety of small molecule structural analogs, and the concentration of some structural analogs is many times higher than that of the target. Therefore, these structural analogs have strong cross-reactions with the nucleic acid aptamers of the target, resulting in inaccurate determination of the target content, and even inability to achieve quantitative detection. At present, there are very few nucleic acid aptamers whose specificity can meet the needs of clinical detection.
[0004] In addition, the traditional SELEX technology is cumbersome to operate and has a long screening cycle. In order to speed up the screening process of nucleic acid aptamers, a variety of improved SELEX technologies have been developed in recent years to shorten the screening cycle. These improved technologies improve the separation steps in the SELEX process and replace the traditional separation technology based on affinity columns or cellulose acetate membranes with more efficient or convenient separation methods. These improved methods include: magnetic bead separation (Nucleic Acids Research 2003, 31 (18), e110-e118), capillary electrophoresis (Analytical Chemistry 2004, 76 (18), 5387-5392), gel electrophoresis (Nucleic Acids Research 2005, 33 (17), e141-e147), microfluidic chip method (Proc. Natl. Acad. Sci. USA 2009, 106, 2989-2994), surface plasmon resonance (Analytical Biochemistry 2005, 342 (2), 312-317). However, most of these methods are only applicable to speeding up the screening of protein target aptamers, and the screening of small molecule target aptamers is still inefficient, and new rapid screening technologies are urgently needed.
[0005] Among the various current screening technologies for nucleic acid aptamers for small molecule targets, the three most commonly used methods are: (1) Methods based on target fixation. In this method, the small molecule target is fixed on magnetic beads or agarose balls, the magnetic beads or agarose balls are incubated with the library, and then the magnetic beads or agarose balls are separated, and the nucleic acid sequences adsorbed on the magnetic beads or agarose balls are eluted to achieve library enrichment. In this method, there is serious nonspecific adsorption of the solid phase matrix. In addition, the fixation of the target on the solid phase surface will also mask the binding site of the target and affect the conformation of the target. Therefore, the enrichment efficiency of the library is usually very low or even fails. It usually takes 10-20 rounds to obtain nucleic acid aptamers with dissociation constants of nanomoles per liter to micromoles per liter. (2) Methods based on library fixation. In this method, the random library is assembled on magnetic beads or agarose balls through complementary capture chains, the magnetic beads or agarose balls are incubated with the target, and then the magnetic beads or agarose balls are separated and the supernatant is collected to achieve library enrichment. This method has been widely used in the screening of small molecule target aptamers in recent years, but there are problems such as serious library self-dissociation and low enrichment efficiency. (3) Screening method of homogeneous aptamers. This method does not require the target molecule or library to be fixed to a solid phase medium, but directly incubates the library with the target molecule in a solution, and then uses the difference in the adsorption force of nanomaterials such as graphene oxide on single-stranded unbound sequences and partially folded sequences bound to the target (Chemical Communications 2014, 50(72), 10513-10516) to separate and enrich the library. Since the target molecule is in a free and free state during the screening process, which is the same as the state in the actual sample, the aptamers obtained by the homogeneous screening technology are theoretically more suitable for later applications. Although the screening method of homogeneous aptamers overcomes the problems of the aptamer screening method based on fixed targets or fixed libraries, it still has certain defects. The separation efficiency of graphene oxide separation is greatly affected by the physical properties of the target and is difficult to control.
[0006] Small molecule structural analogs contain two parts in molecular structure: a common domain and a proprietary domain. In theory, nucleic acid aptamers that can bind to both the proprietary domain and the common domain at the same time and have a higher affinity for the proprietary binding domain will have higher specificity and lower cross-reaction to their structural analogs. However, the binding position of the nucleic acid aptamers obtained by the above-mentioned method for screening small molecule target nucleic acid aptamers with the target and the affinity for the common domain and the proprietary domain are all uncertain. In order to obtain nucleic acid aptamers for small molecule targets with high specificity, it is urgent to develop a new method for rapid screening of nucleic acid aptamers with regional selectivity.
[0007] Organic reactions with regioselectivity have promoted the revolutionary development of synthesis and medicinal chemistry. Classical regio- or position-selective organic reactions are achieved by using covalent protecting groups. In recent years, non-covalent interactions have also developed into a new method for controlling the regio- or position-selectivity of organic reactions. RNA aptamers are used to protect small molecules so that among multiple functional groups with similar reactivity, only one functional group that is not bound to or shielded by the aptamer can undergo chemical reactions (Aptamer protective groups tolerate different reagents and reactions for regioselective modification of neomycin B.Org.Biomol.Chem.2020, 18(47), 9606-9610; Selective transformations of complex molecules are enabled by aptameric protective groups.Nat.Chem.2012, 4(10), 789-793; Probing the shielding properties of aptameric protective groups.Chem.Asian J.2014, 9(8), 2225-2231). In response to the phenomenon that the above-mentioned nucleic acid aptamer binds to the target and inhibits the organic reaction of the functional groups in the bound or masked region on the target, the present invention provides a method for screening nucleic acid aptamers for small molecule targets with regional selectivity. Summary of the invention
[0008] The present invention aims to provide a method for screening nucleic acid aptamers for small molecule targets with regional selectivity. The method is based on the phenomenon that nucleic acid-target binding inhibits organic reactions of functional groups in the bound or masked regions on the target, and comprises the following steps: step 1, heat treatment of the library; step 2, activation of magnetic beads or agarose spheres; step 3, negative screening of magnetic beads or agarose spheres; step 4, incubation of the library with the target; step 5, capturing nucleic acid sequences bound to the target through a cross-linking reaction; step 6, elution of bound nucleic acids on the magnetic beads or agarose spheres; step 7, PCR; step 8, preparation of single-stranded DNA.
[0009] In the above method, steps 4 and 5 use the following principle: taking the screening of amino acid aptamers as an example, aptamers that bind to the side chain R of the amino acid-specific domain are screened. The amino acid contains an α-amino group (amine group-NH2), a carboxyl group and a side chain R. The aptamer binds to multiple domains of the amino acid molecule. Some sequences bind to both the amine group and R; some sequences bind strongly to the amine group, but do not bind to R or bind weakly to R; some sequences bind strongly to R, but do not bind to the amine group or bind weakly. Among these aptamers, the sequences that bind strongly to R, but do not bind to the amine group or bind weakly are expected to have the best The specificity of the aptamer is that the amine groups that bind strongly to the aptamer or the amine groups masked by the bound sequence cannot undergo cross-linking reaction with the activated carboxyl groups on the magnetic beads or agarose, and therefore are not enriched by the magnetic beads or agarose balls; while the amine groups that do not bind or weakly bind to the aptamer can undergo cross-linking reaction with the activated carboxyl groups on the magnetic beads or agarose, and therefore are captured and enriched by the magnetic beads or agarose balls, thus realizing nucleic acid aptamers with high affinity for the side chain R. Different types of functionalized magnetic beads or agarose are selected according to different target molecular structures, and some types of functionalized magnetic beads or agarose do not require the activation treatment in step 2.
[0010] The above steps 1-8 are repeated 2-5 times to achieve rapid enrichment of the library.
[0011] In the above method,
[0012] Step 1: Heat treatment of the library is as follows: Take an appropriate amount of the library and heat it in a buffer solution: heat it in a 95°C water bath, cool it in an ice bath, and place it at room temperature;
[0013] Step 2. Depending on the target molecular structure, the type of functionalized magnetic beads or agarose selected is different. Some types of functionalized magnetic beads or agarose do not require the activation treatment of step 2. When the common structural domain of the target molecule has a primary amine group, carboxyl-functionalized magnetic beads or agarose spheres can be used. The activation of magnetic beads or agarose spheres is as follows: Activate the carboxyl-modified magnetic beads or agarose spheres with N-hydroxysuccinimide (NHS) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to generate NHS active ester-modified magnetic beads or agarose spheres;
[0014] Step 3, negative screening with magnetic beads or agarose beads is as follows: take part of the NHS-activated magnetic beads prepared in step 2 and incubate with the library in step 1, separate by magnetic or gravity, and use the supernatant in step 4;
[0015] Step 4, incubation of the library with the target is as follows: the library collected in step 3 is mixed and incubated with the target in a certain molar ratio in the screening buffer; in order to reduce the number of free small molecules (not bound to the aptamer) in the system, the library is in large excess in this step. Note that when using traditional SELEX to screen small molecule target aptamers, the small molecule target is in large excess compared to the library, usually in the micromolar or even millimolar concentration range. In the present invention, the library is in excess, and the concentration of the small molecule target is as low as the nanomolar range.
[0016] Step 5, capturing the nucleic acid sequence bound to the target by cross-linking reaction as follows: incubating the NHS-activated magnetic beads prepared in step 2 with the library and target mixture in step 4, separating them magnetically or by gravity, and washing the magnetic beads;
[0017] Step 6, eluting the nucleic acid bound to the magnetic beads or agarose spheres as follows: incubating a certain amount of proteinase K with the magnetic beads or agarose spheres obtained in step 5, or heating the magnetic beads or agarose spheres obtained in step 5 with a buffer solution, incubating, and collecting the supernatant;
[0018] Step 7, PCR is as follows: the eluate obtained in step 6 is subjected to PCR, and the PCR product is purified by ethanol precipitation;
[0019] Step 8, single-stranded DNA is prepared as follows: Single-stranded DNA can be prepared by various methods such as biotin-streptavidin method, long-short chain gel electrophoresis method, lambda phage exonuclease method, etc. The lambda phage exonuclease method includes using lambda phage exonuclease to degrade the 5' phosphate-modified antisense strand in the PCR product, purifying the enzyme digestion product by ethanol precipitation, and quantifying each round of products by ultraviolet. The obtained single-stranded DNA library is a secondary library, which enters the next round of screening or cloning and sequencing.
[0020] The above also includes the following steps:
[0021] (1) Select representative enriched sequences for chemical synthesis;
[0022] (2) Affinity, selectivity and functionality testing of chemically synthesized sequences.
[0023] In order to further improve the target specificity of nucleic acid aptamers, negative screening of potential interferents or structural analogs can be performed after 3-5 rounds of library enrichment, including the following steps:
[0024] (1) When negative screening is performed on potential interferents with a large structural difference from the target molecule, a negative screening step for potential interferents is added before the above step 4. The specific operation is to incubate the library with magnetic beads or agarose beads coated with potential interferents, and take the supernatant for step 4.
[0025] (2) When negative screening is performed on structural analogs of the target molecule, a negative screening step for structural analogs is added before the above step 4. The specific operation is to incubate the library with the structural analogs, add magnetic beads or agarose beads that can undergo cross-linking reactions with the proprietary domains of the structural analogs, and take the supernatant for step 4.
[0026] The method of the present invention has the following advantages:
[0027] 1. The method of the present invention can screen out nucleic acid aptamers with regional selectivity for small molecule targets. The nucleic acid aptamers have high affinity for the proprietary domain and relatively weak affinity for the shared binding domain. Therefore, the nucleic acid aptamers have high specificity for the target and low cross-reactivity to the structural analogs of the target;
[0028] 2. The method of the present invention utilizes orthogonal organic reactions with mild reaction conditions, has high reaction efficiency, and has good compatibility with aqueous solution systems, so the enrichment efficiency of the library is high;
[0029] 3. In the method of the present invention, the target and the library are incubated in a homogeneous system, and the binding process is not interfered by the solid phase interface, which overcomes the defect of the target being fixed on the solid phase in the existing screening technology, avoids the problem of surface fixation masking the target binding site and affecting the target conformation, and also greatly reduces the non-specific adsorption of the solid phase medium to the library, which is very beneficial to accelerate the screening efficiency of nucleic acid aptamers;
[0030] 4. The method of the present invention separates the nucleic acid sequence bound to the target by magnetic separation technology or agarose gravity separation, does not require expensive or special equipment, is simple and fast to operate, and does not require any condition optimization. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 The schematic diagram of step 4 and step 5 of the method of the present invention for screening nucleic acid aptamers with regional selectivity for small molecule targets. Taking the screening of amino acid nucleic acid aptamers as an example, nucleic acid aptamers that bind to the side chain R of the amino acid-specific domain are screened.
[0032] Figure 2 The schematic diagram is a schematic diagram of the whole process of the method of the present invention for screening nucleic acid aptamers with regional selectivity for small molecule targets. Taking the screening of amino acid nucleic acid aptamers as an example, nucleic acid aptamers that bind to the side chain R of the amino acid-specific domain are screened.
[0033] Figure 3 These are the cross-reaction test data of the highly specific homocysteine nucleic acid aptamer screened by the method of the present invention with other amino acids and human serum albumin.
[0034] Figures 4a-4dIt is the test data of circular dichroism spectra of the highly specific homocysteine nucleic acid aptamer screened by the present invention and other amino acids. DETAILED DESCRIPTION
[0035] Figure 1 Schematic diagram of steps 4 and 5 of the method of the present invention for screening nucleic acid aptamers with regional selectivity for small molecule targets. Taking the screening of amino acid nucleic acid aptamers as an example, nucleic acid aptamers that bind to the side chain R of the amino acid-specific domain are screened. Figure 1 As shown, amino acids contain α-amino groups (amine-NH2), carboxyl groups, and side chains R. Nucleic acid aptamers bind to multiple domains of amino acid molecules, such as some sequences that bind to both amine groups and R; some sequences that bind strongly to amine groups but do not bind to R or bind weakly to R; and some sequences that bind strongly to R but do not bind to amine groups or bind weakly to R. Among these nucleic acid aptamers, sequences that bind strongly to R but do not bind to amine groups or bind weakly to amine groups are expected to have the best specificity. Amine groups that bind strongly to aptamers or are masked by the bound sequence cannot undergo cross-linking reactions with activated carboxyl groups on magnetic beads or agarose, and therefore are not enriched by magnetic beads or agarose spheres; while amine groups that do not bind to aptamers or bind weakly can undergo cross-linking reactions with activated carboxyl groups on magnetic beads or agarose, and therefore are captured and enriched by magnetic beads or agarose spheres. In this way, nucleic acid aptamers with high affinity for side chain R are achieved. Depending on the target molecular structure, the type of functionalized magnetic beads or agarose selected is different. Some types of functionalized magnetic beads or agarose do not require the activation treatment of step 2.
[0036] Figure 2 This is a schematic diagram of the whole process of the method of the present invention for screening nucleic acid aptamers with regional selectivity for small molecule targets. Each screening cycle includes 1. heat treatment of the library; 2. activation of magnetic beads to generate magnetic beads modified with NHS active esters; 3. negative screening of magnetic beads: incubation of NHS-activated magnetic beads with the library in 1, magnetic separation, and removal of nucleic acid sequences bound to the activated magnetic beads; 4. incubation of the library with the target; 5. capture of nucleic acid sequences bound to the target through cross-linking reaction; 6. elution of nucleic acids bound to the magnetic beads: thermal elution or proteinase K hydrolysis of the target to achieve nucleic acid elution; 7. PCR; 8. preparation of single-stranded DNA.
[0037] Example 1. A method for screening homocysteine (Hcy) nucleic acid aptamers with regional selectivity is provided by utilizing the phenomenon that nucleic acid-target binding inhibits organic reactions of functional groups in the bound or masked regions on the target.
[0038] The following screening steps are Figure 2 As shown:
[0039] (1) Heat treatment of the initial DNA library: Take 5 μL of 100 μM single-stranded DNA library and add it to the screening buffer to make the total volume of the solution 490 μL. Heat in a 95°C water bath for 10 minutes, cool in an ice bath for 5 minutes, and leave at room temperature for 5 minutes.
[0040] (2) Incubation of library with Hcy: 100 (first round screening)-15 (2nd-4th round screening) pmoles of Hcy were added to the heat-treated DNA library and incubated at room temperature for 1 hour.
[0041] (3) Activation of magnetic beads: Take 10 μL of the mixed magnetic beads and place them in a 1.5 milliliter (mL) centrifuge tube, and wash them three times with 100 μL of 25 mM 2-(N-morpholino)ethanesulfonic acid (MES) solution. Use cold 25 mM MES solution to freshly prepare 100 μL of 50 mg / mL EDC solution and 50 mg / mL NHS solution. First add 50 μL of the freshly prepared EDC solution to the washed magnetic beads and mix well, then add 50 μL of the freshly prepared NHS solution and mix well. Place the centrifuge tube on a rotating mixer and rotate at low speed at room temperature for 30 minutes. After the rotation, place the centrifuge tube containing the magnetic beads on a strong magnet and let it stand for 4 minutes, and remove the supernatant. The activated magnetic beads are washed four times with 100 μL MES solution. Then add the screening buffer.
[0042] (4) Incubation of magnetic beads with DNA-Hcy complex: Add all activated magnetic beads to the solution after DNA-Hcy incubation, with a total volume of 500 μL, and incubate at room temperature for 60 minutes.
[0043] (5) DNA elution: After incubation, magnetic beads were separated by magnetic separation, supernatant was discarded, 200 μL of screening buffer containing 0.1% Tween-20 was added to the magnetic beads, and the beads were washed repeatedly for 4 times, and the elution was retained each time. The volume was made up to 120 μL with screening buffer (110 μL of screening buffer was added), heated at 95°C for 20 min, magnetically separated, and the supernatant was aspirated into a new centrifuge tube and stored in a -20°C freezer.
[0044] (6) Small-scale PCR: Take 8 200 μL centrifuge tubes and label the tube walls with Blank 10, Blank 15, Blank 20, Blank 25, PCR 10, PCR 15, PCR 20, and PCR 25. Add 6 μL of nuclease-free water, 2 μL of 10 μM forward primer, 2 μL of 10 μM biotin-modified reverse primer, and 10 μL of 2× Premix in the blank tubes. Hot Start. In a centrifuge tube labeled PCR, add 4 μL of nuclease-free water, 2 μL of 10 μM forward primer, 2 μL of 10 μM biotin-modified reverse primer, 10 μL of 2× Premix in the order Hot Start and 2 μL of the product obtained from (5). The PCR instrument was set up according to the following program: pre-melting treatment at 95°C for 1 minute (min); 25 cycles: 95°C for 30 seconds, 60°C for 30 seconds, 72°C for 30 seconds (s); 72°C for 2 minutes; 4°C for 6 minutes. When running the program, the sample heating volume was set to 20 μL. When the instrument ran to 20 seconds of the extension step of the 10th, 15th, 20th, and 25th rounds, the program was paused, the instrument cover was opened, the tubes with corresponding labels were taken out, and they were stored at 4°C, and then the program was continued until the reaction was completed.
[0045] Prepare 12% denaturing polyacrylamide gel (PAGE), add 4.8 μL nuclease-free water, 6 μL 2x RNA loading solution and 1.2 μL PCR product in a 200 μL centrifuge tube, and mix well. Heat treat at 95°C for 10 minutes and ice bath for 5 minutes. Then add the heat-treated sample to the vertical electrophoresis system, perform pre-electrophoresis and electrophoresis at 170 volts (V), the electrophoresis solution is 1×TBE buffer, and the electrophoresis time is 45 minutes. After electrophoresis, the gel is used The gold nucleic acid dye was used for staining in 1× TBE buffer for 10 minutes, and electrophoresis photos were taken using a gel imaging system.
[0046] (7) According to the gel electrophoresis results in (6), after selecting the optimal number of amplification rounds, perform PCR amplification on all samples obtained in (5). Prepare several 200 μL centrifuge tubes, and add 20 μL of nuclease-free water, 10 μL of forward primer, 10 μL of 10 μM biotin-modified reverse primer, and 50 μL of 2× Premix to each centrifuge tube. Hot Start and 10 μL of the product obtained from (5). The PCR instrument was set according to the following program: pre-melting treatment at 95°C for 1 min; 25 cycles: 95°C for 30 s, 60°C for 30 s, 72°C for 30 s; 72°C for 2 min; 4°C for 6 min. When running the program, the sample heating volume was set to 100 μL.
[0047] (8) After the PCR reaction is completed, the obtained samples are mixed, 60 μL of agarose beads coated with streptavidin protein are added to the homemade agarose column, and the column is passed twice with 1×PBS. 100 μL of amplified product is added, the column is allowed to stand for 5 minutes, the column is passed, and the column is passed once with 1×PBS. The above steps are repeated until all amplified products have been incubated with the separation column. After that, 100 μL of 30 mM NaOH solution is added, the column is allowed to stand for 5 minutes, the column is passed, and the liquid passing through the homemade column is collected and neutralized with 2 M dilute hydrochloric acid.
[0048] (9) After repeating (1-8) 4 times, the enriched library was sent for commercial high-throughput sequencing;
[0049] (10) Select representative sequences for chemical synthesis.
[0050] Example 2. Specific detection of Hcy aptamers using an evanescent wave optical fiber aptamer sensor.
[0051] In the evanescent wave optical fiber aptamer sensor, the preferred Hcy aptamer obtained in Example 1 is terminally amino-modified and fixed on the optical fiber by covalent coupling; Hcy or potential interferents, structural analogs and fluorescently labeled complementary DNA chains in the solution compete with the aptamer on the optical fiber, thereby achieving target-specific detection of the Hcy aptamer ( Figure 3 ). The higher the affinity between the test molecule and the aptamer, the weaker the binding between the complementary DNA chain and the aptamer on the optical fiber, the lower the fluorescence response value compared to the fluorescence response value of the blank sample containing only the complementary DNA chain, and the greater the decrease in relative fluorescence intensity.
[0052] Specific test results such as Figure 3 As shown, the relative fluorescence intensity decrease caused by the sample containing 1 pM Hcy is higher than that of 100 nM other amino acids (methionine Met, histidine His, arginine Arg, cysteine Cys) and human serum albumin HSA, indicating that the nucleic acid aptamer has extremely high target specificity for Hcy (>100,000 times).
[0053] Example 3. Specific detection of Hcy nucleic acid aptamers using circular dichroism spectroscopy.
[0054] Circular dichroism (CD) is the most widely used rapid and simple method for determining the secondary structure of proteins and nucleic acids in solution.
[0055] like Figure 4a As shown, the CD spectrum signals of Hcy, cysteine Cys, and glutathione GSH in the range of 250-310 nm are extremely weak and can be ignored, and there are strong absorptions of varying degrees in the range of 220-250 nm.
[0056] like Figure 4b As shown in the black line in the middle, the Hcy aptamer has strong CD absorption in the range of 240-310nm, a strong negative peak near 245nm, and a positive peak at 260-290nm. This indicates that the Hcy aptamer has a right-handed B-configuration DNA structure, which is consistent with the hairpin structure predicted based on the sequence information (the hairpin structure is a variant of the B-configuration DNA structure). Figure 4b As shown in the red line in the middle, when the sample contains 100 μM Hcy, the intensity of the negative peak of Hcy's aptamer near 245nm and the positive peak at 260-290nm decreases significantly. This data shows that the binding of Hcy and aptamer weakens the stability of the B-configuration DNA structure, confirming the strong interaction between Hcy and aptamer.
[0057] like Figure 4c and 4d As shown in the red line in the middle, when the sample contains 2mM Cys or 5mM GSH, the CD spectrum signal intensity of Hcy's aptamer in the range of 250-310nm changes very little. This data shows that the structural analogs of Hcy, Cys and GSH, have weak interactions with the aptamer even when the concentration is 20 times and 50 times higher than that of Hcy.
[0058] The above data confirm that the Hcy nucleic acid aptamer obtained by screening according to the method of the present invention has high specificity and does not bind to Cys with only one methylene difference. The high specificity of the Hcy nucleic acid aptamer may be related to the fact that the side chain R of Hcy and the peptide bond backbone may form a five-membered ring stable structure, while other amino acids or structural analogs including Cys cannot. The high specificity of the Hcy nucleic acid aptamer indicates that the side chain R of Hcy is its high affinity binding site with the nucleic acid aptamer, rather than the common structural domain of the amino acid.
[0059] The above description is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. A method for screening nucleic acid aptamers with regional selectivity for small molecule targets, characterized in that: The method is based on the phenomenon that nucleic acid-target binding inhibits organic reactions of functional groups in bound or masked regions on the target, and comprises the following steps: step 1, heat treatment of the library; step 2, activation of magnetic beads or agarose spheres; step 3, negative screening of magnetic beads or agarose spheres; step 4, incubation of the library with the target; step 5, capturing nucleic acid sequences bound to the target through a cross-linking reaction; step 6, elution of bound nucleic acids on the magnetic beads or agarose spheres; step 7, PCR; and step 8, preparation of single-stranded DNA.
2. The method according to claim 1, characterized in that Steps 4 and 5 use the following principle: Taking the screening of amino acid aptamers as an example, aptamers that bind to the side chain R of the amino acid-specific domain are screened. Amino acids contain an α-amino group (amine group-NH2), a carboxyl group and a side chain R. Aptamers bind to multiple domains of amino acid molecules. Some sequences bind to both the amine group and R; some sequences bind strongly to the amine group, but do not bind to R or bind weakly to R; some sequences bind strongly to R, but do not bind to the amine group or bind weakly. Among these aptamers, sequences that bind strongly to R, but do not bind to the amine group or bind weakly are expected to have the best specificity. The amine groups that bind strongly to the aptamer or are masked by the bound sequence cannot undergo cross-linking reaction with the activated carboxyl groups on the magnetic beads or agarose, and are therefore not enriched by the magnetic beads or agarose balls; while the amine groups that do not bind or weakly bind to the aptamer can undergo cross-linking reaction with the activated carboxyl groups on the magnetic beads or agarose, and are therefore captured and enriched by the magnetic beads or agarose balls, thereby achieving nucleic acid aptamers with high affinity for the side chain R. Different types of functionalized magnetic beads or agarose are selected according to different target molecular structures, and some types of functionalized magnetic beads or agarose do not require the activation treatment in step 2.
3. The method according to claim 1 or 2, characterized in that: Repeat the above steps 1-8 for 2-5 rounds to achieve rapid enrichment of the library. In the above method, Step 1: Heat treatment of the library is as follows: Take an appropriate amount of the library and heat it in a buffer solution: heat it in a 95°C water bath, cool it in an ice bath, and place it at room temperature; Step 2: Depending on the target molecular structure, the type of functionalized magnetic beads or agarose used is different. Some types of functionalized magnetic beads or agarose do not require the activation treatment of step 2. When the common structural domain of the target molecule has a primary amine group, carboxyl-functionalized magnetic beads or agarose spheres can be used. The activation of the magnetic beads or agarose spheres is as follows: the carboxyl-modified magnetic beads or agarose spheres are activated with N-hydroxysuccinimide (NHS) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to generate NHS active ester-modified magnetic beads or agarose spheres; Step 3, negative screening with magnetic beads or agarose beads is as follows: take part of the NHS-activated magnetic beads prepared in step 2 and incubate with the library in step 1, separate by magnetic or gravity, and use the supernatant in step 4; Step 4, incubating the library with the target is as follows: the library collected in step 3 and the target are mixed and incubated in a screening buffer at a certain molar ratio; in order to reduce the number of free small molecules (not bound to nucleic acid aptamers) in the system, the library is in large excess in this step. Note that when using traditional SELEX to screen small molecule target nucleic acid aptamers, the small molecule target is in large excess compared to the library, usually in the micromolar or even millimolar concentration range, where the library is in excess and the concentration of the small molecule target is as low as the nanomolar range; Step 5, capturing the nucleic acid sequence bound to the target by cross-linking reaction as follows: incubating the NHS-activated magnetic beads prepared in step 2 with the library and target mixture in step 4, separating them magnetically or by gravity, and washing the magnetic beads; Step 6, eluting the nucleic acid bound to the magnetic beads or agarose spheres as follows: incubating a certain amount of proteinase K with the magnetic beads or agarose spheres obtained in step 5, or heating the magnetic beads or agarose spheres obtained in step 5 with a buffer solution, incubating, and collecting the supernatant; Step 7, PCR is as follows: the eluate obtained in step 6 is subjected to PCR, and the PCR product is purified by ethanol precipitation; Step 8, single-stranded DNA is prepared as follows: Single-stranded DNA can be prepared by various methods such as biotin-streptavidin method, long-short chain gel electrophoresis method, lambda phage exonuclease method, etc., wherein the lambda phage exonuclease method includes using lambda phage exonuclease to degrade the 5' phosphate-modified antisense strand in the PCR product, purifying the enzyme digestion product by ethanol precipitation method, and quantifying each round of products by ultraviolet. The obtained single-stranded DNA library is the secondary library, and the secondary library enters the next round of screening or cloning and sequencing.
4. The method according to claim 3, characterized in that The following steps are also included: (1) Select representative enriched sequences for chemical synthesis; (2) Affinity, selectivity and functionality testing of chemically synthesized sequences.
5. The method according to claim 4, characterized in that In order to further improve the target specificity of nucleic acid aptamers, negative screening of potential interferents or structural analogs can be performed after 3-5 rounds of library enrichment, including the following steps: (1) When negative screening is performed on potential interferents with a large structural difference from the target molecule, a negative screening step for potential interferents is added before the above step 4. The specific operation is to incubate the library with magnetic beads or agarose beads coated with potential interferents, and take the supernatant for step 4; (2) When negative screening is performed on structural analogs of the target molecule, a negative screening step for the structural analogs is added before the above step 4. The specific operation is to incubate the library with the structural analogs, add magnetic beads or agarose beads that can undergo cross-linking reactions with the proprietary domains of the structural analogs, and take the supernatant for step 4.
